Commit Biologics

Commit Biologics is a Danish biotechnology company developing complement-powered immune engagers, a new class of immunotherapies that redirect the complement system against diseased cells. Its proprietary Bispecific Complement Engager (BiCE) platform engineers IgG antibodies that recruit the complement protein C1q to selectively eliminate targeted cells through a T-cell-independent mechanism. A spin-out from Aarhus University operating from Copenhagen and Aarhus, its lead candidate COM002 targets relapsed or refractory non-Hodgkin lymphoma with potential expansion into autoimmune diseases, and the company is backed by Ackermans & van Haaren, AbbVie Ventures, M Ventures, Bioqube Ventures, Korys and Novo Holdings.

  • Seed
  • Biotechnology
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Nov 17, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 17, 2026

    EUR 54M

    Seed

    Led by Ackermans & van Haaren (AvH)

    • Novo Holdings
    • Korys
    • M Ventures
    • Ackermans & van Haaren (AvH)
    • AbbVie Ventures
    • Bioqube Ventures

    Article coming soon.

Pricing

Research Commit Biologics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Commit Biologics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational